Business Context and Reporting Period
This Form 8-K Current Report was filed by Silvaco Group, Inc. on May 8, 2026. The filing addresses an amendment to the Company's existing At-The-Market (ATM) equity offering program and a change in its regulatory status regarding public float limitations.
Key Financial Metrics and Capital Structure
- ATM Program Capacity: Increased from $15.0 million to $35.0 million in aggregate offering amount.
- Shares Sold to Date: As of May 7, 2026, the Company sold 752,744 shares under the program.
- Proceeds to Date: Approximately $4,331,280.
- Remaining Capacity: Approximately $30,668,720 available for future sales under the amended program.
- Stock Price: Reported at $12.46 per share on May 6, 2026 (Nasdaq Global Select Market).
- Public Float: Calculated at $175,270,596 based on 14,066,661 shares held by non-affiliates.
- Outstanding Shares: 32,688,557 shares as of May 6, 2026.
Note: This filing does not provide data on revenue, profit, cash flow, operating margins, debt levels, or liquidity ratios.
Material Changes
- Program Expansion: The Company filed a prospectus supplement to increase the maximum amount of common stock it may sell under its ATM program by an additional $20.0 million.
- Regulatory Status Change: The Company's public float exceeded the $75 million threshold. Consequently, it is no longer subject to the "baby shelf" limitations (General Instruction I.B.6 of Form S-3) and may now rely on General Instruction I.B.1, allowing for the sale of additional securities without prior 12-month limitations.
Outlook, Risks, and Management Commentary
Management indicated that the increase in the ATM program capacity provides flexibility to raise capital as needed. The filing includes a legal opinion from White & Case LLP regarding the validity of the additional shares. The document contains standard disclaimers that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Key Facts for Investor Verification
- Verify the exact number of shares sold and proceeds received in subsequent filings to track the utilization of the new $30.7 million capacity.
- Monitor the Company's public float to ensure it remains above the $75 million threshold to maintain the expanded Form S-3 eligibility.
- Review the Company's most recent 10-Q or 10-K for comprehensive financial performance metrics (revenue, earnings, cash flow) which are not included in this 8-K.
- Confirm the impact of the new share issuance on existing shareholder dilution.